pembrolizumab,pds0101
pds biotech,merck
['keytruda', 'pds0101', '$pdsb', 'pds bio', 'merck']
$pdsb is up 20.52% as pds biotechnology will discuss interim data from versatile-002 trial investigating pds0101 with merck's keytruda at asco meeting. 
Stock Market Trader - Follow your own opinions